Senin, 12 Maret 2018

ARTICLE TRANSLATION




NO.
SL
GOOGLE TRANSLATE
TL
STRATEGY
(NEWMARK)
1.

Alzheimer's researchers win brain prize,

By Michelle RobertsHealth editor, BBC News online

Peneliti Alzheimer memenangkan hadiah otak,
Oleh Michelle RobertsHealth editor, BBC News online
Para peneliti penyakit Alzheimer memenangkan penghargaan pembedahan otak, Oleh penyunting Michelle Roberts Health, berita daring BBC
Free Translation
2.
Four dementia scientists have shared this year’s 1m Euro brain prize for pivotal work that has changed our understandeing of Alzheimer’s disease.
Empat ilmuwan demensia telah membagikan hadiah otak Euro 1m tahun ini untuk pekerjaan penting yang telah mengubah pemahaman kita tentang penyakit Alzheimer.
Empat ilmuan demensia telah mendapatkan penghargaan   Brain Prize sebesar satu juta Euro tahun ini untuk pekerjaan penting yang telah mengubah pemahaman kita mengenai penyakit Alzheimer.
Adaptation, Literal, Free
3.
Profs John Hardy, Bart De Strooper, Michel Goedert, based in the UK, and Prof Christian Haass, from Germany, unpicked key protein changes that lead to this most common type of dementia.
Prof John Hardy, Bart De Strooper, Michel Goedert, yang berbasis di Inggris, dan Prof Christian Haass, dari Jerman, tidak dipalsukan mengubah protein kunci yang menyebabkan jenis demensia yang paling umum ini.
Prof. John Hardy, Bart De Strooper, Michel Goedert, yang berbasis di Brittania Raya, dan Prof. Christian Haass, dari Jerman, tidak memalsukan perubahan protein kunci yang menyebabkan jenis demensia yang paling umum ini.
Literal, Free
4.
On getting the award, Prof Hardy said he hoped new treatments could be found.
Dalam mendapatkan penghargaan tersebut, Prof Hardy mengatakan bahwa ia berharap perawatan baru dapat ditemukan.
Dalam meraih penghargaan tersebut, Prof Hardy mengatakan bahwa ia berharap ada perawatan baru yang dapat ditemukan.
Faithful Translation
5.
He is donating some of his prize money to care for Alzheimer's patients.

Dia menyumbangkan sebagian dari uang hadiahnya untuk merawat pasien Alzheimer.
Dia menyumbangkan sebagian dari uang hadiahnya untuk merawat pasien Alzheimer.
Faithful translation
6.
Much of the drug discovery research that's done today builds on their pioneering work, looking for ways to stop the build-up of damaging proteins, such as amyloid and tau.
Sebagian besar penelitian penemuan obat yang dilakukan hari ini didasarkan pada karya perintis mereka, mencari cara untuk menghentikan penumpukan protein yang merusak, seperti amiloid dan tau.
Banyak penelitian tentang penemuan obat yang sudah dilakukan hari ini didasarkan pada karya perintis mereka, mencari cara untuk menghentikan peningkatan pembangunan yang merusak protein, seperti amiloid dan tau.
Faithful Translation
7.
Alzheimer's and other dementias affect 50 million people around the world, and none of the treatments currently available can stop the disease.
Alzheimer dan demensia lainnya mempengaruhi 50 juta orang di seluruh dunia, dan tidak satu pun perawatan yang tersedia saat ini dapat menghentikan penyakit ini.
Penyakit Alzheimer dan demensia lainnya merusak 50 juta orang di seluruh dunia, dan tidak ada satu pun perawatan yang tersedia saat ini dapat menghentikan penyakit ini.
Faithful Translation
8.
Path to beating Alzheimer's, Prof Hardy's work includes finding rare, faulty genes linked to Alzheimer's disease.
Jalan untuk mengalahkan Alzheimer, pekerjaan Prof Hardy mencakup menemukan gen langka dan salah yang terkait dengan penyakit Alzheimer.
Cara untuk mengalahkan Alzheimer, penemuan Prof. Hardy termasuk menemukan gen cacat yang terhubung dengan penyakit Alzheimer
Faithful Translation
9.
These genetic errors implicated a build-up of amyloid as the event that kick-starts damage to nerve cells in Alzheimer's.
Kesalahan genetik ini melibatkan pembentukan amiloid sebagai kejadian yang menendang mulai merusak sel-sel saraf di Alzheimer.
Kesalahan genetic ini melibatkan pembentukan amiloid sebagai hal pertama yang menyebabkan kerusakan pada sel-sel saraf Alzheimer.
Free Translation
10.
This idea, known as the amyloid cascade hypothesis, has been central to Alzheimer's research for nearly 30 years.
Ide ini, yang dikenal sebagai hipotesis kaskade amiloid, telah menjadi inti penelitian Alzheimer selama hampir 30 tahun.
Gagasan yang dikenal sebagai hipotesis kaskade amiloid ini telah menjadi inti dari peneletian Alzheimer selama hampir 30 tahun.
Free Translation

Alzheimer's researchers win brain prize

By Michelle RobertsHealth editor, BBC News online

6 March 2018


Four dementia scientists have shared this year's 1m Euro brain prize for pivotal work that has changed our understanding of Alzheimer's disease.

Profs John Hardy, Bart De Strooper, Michel Goedert, based in the UK, and Prof Christian Haass, from Germany, unpicked key protein changes that lead to this most common type of dementia.

 On getting the award, Prof Hardy said he hoped new treatments could be found. He is donating some of his prize money to care for Alzheimer's patients.
Much of the drug discovery research that's done today builds on their pioneering work, looking for ways to stop the build-up of damaging proteins, such as amyloid and tau. Alzheimer's and other dementias affect 50 million people around the world, and none of the treatments currently available can stop the disease.
Path to beating Alzheimer's,
Prof Hardy's work includes finding rare, faulty genes linked to Alzheimer's disease. These genetic errors implicated a build-up of amyloid as the event that kick-starts damage to nerve cells in Alzheimer's.
This idea, known as the amyloid cascade hypothesis, has been central to Alzheimer's research for nearly 30 years. Together with Prof Haass, who is from the University of Munich, Prof Hardy, who's now at University College London, then discovered how amyloid production changes in people with rare inherited forms of Alzheimer's dementia.
Prof Goedert's research at Cambridge University, meanwhile, revealed the importance of another damaging protein, called tau, while Prof De Stooper, who is the new director of the UK Dementia Research Institute at UCL, discovered how genetic errors that alter the activity of proteins called secretases can lead to Alzheimer's processes.
Dr David Reynolds, Chief Scientific Officer at Alzheimer's Research UK, said: "Our congratulations go to all four of these outstanding scientists whose vital contributions have transformed our understanding of the complex causes of Alzheimer's disease.
"The fact that three of these researchers work in the UK reflects the country's position as a global leader in dementia research."
Prof Hardy said he would be donating around 5,000 euros of his share of the 1m euros from the Lundbeck Foundationto help campaigns to keep Britain in the EU, and called Brexit a "unmitigated disaster" for scientific research.
He also pledged his thanks to all the people with Alzheimer's who, over the years, have volunteered to help with dementia research.




Angelina                                 Pathricia M    
Dede Yusri                              Vinny Oliviana
Nanda Jesica
4SA02